Company / Shareholders' Equity
TransMedics Group, Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$473.1M
FY2025
5-year range
$67.9M / $473.1M
FY2021-FY2025
Trend
+107.0%
vs FY2024
Sector context
#112 of 166
Health Care
What the data says
At $473M, TransMedics Group, Inc.'s shareholders' equity ranks #112 of 166 in the Health Care sector. Shareholders' Equity has fluctuated over the past 8 years, ranging from -$192M in FY2018 to $473M in FY2025.
Based on SEC 10-K filings.
$473M in FY2025 with a 5-year CAGR of +35.4%.
Improved from $137M to $473M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +36.2%
- 5-Year CAGR
- +35.4%
- 10-Year CAGR
- -
Sector benchmark
#112 of 166 in Health CareTop 67% of 166This company $473.1M Sector average $5.3B
▼
-91.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +35.4%, indicating consistent growth.
- In FY2025, shareholders' equity increased 107.0% year-over-year.
- Ranks #112 out of 166 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2018.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $473.1M | +107.0% |
| FY2024 | $228.6M | +66.6% |
| FY2023 | $137.2M | -26.8% |
| FY2022 | $187.4M | +176.1% |
| FY2021 | $67.9M | -34.7% |
| FY2020 | $103.9M | +90.1% |
| FY2019 | $54.6M | +128.4% |
| FY2018 | -$192.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026